Andy Chen
Stock Analyst at Wolfe Research
(0)
# 4219
Out of 5,270 analysts
36
Total ratings
39.13%
Success rate
-7.45%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
AnaptysBio | Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Feb 4, 2025 | |
Crinetics Pharmaceut... | Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Feb 4, 2025 | |
89bio | Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Feb 4, 2025 | |
Oruka Therapeutics | Initiates Coverage On: Outperform | 20 | n/a | n/a | 1 | Feb 4, 2025 | |
Vera Therapeutics | Initiates Coverage On: Outperform | 49 | 28.63 | 71.15% | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 19 | 6.6 | 187.88% | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Peer Perform | n/a | n/a | n/a | 2 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 697 | 622.66 | 11.94% | 2 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | n/a | n/a | n/a | 2 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Peer Perform | n/a | n/a | n/a | 3 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Peer Perform | n/a | n/a | n/a | 2 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 65 | 30.14 | 115.66% | 2 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Jun 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Jun 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Jun 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Peer Perform | n/a | n/a | n/a | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Peer Perform | n/a | n/a | n/a | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 1 | Apr 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 17 | 10.15 | 67.49% | 1 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 42 | 76.19 | -44.87% | 1 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 60 | 0.98 | 6022.45% | 1 | Aug 8, 2023 |